Data443 Risk Mitigation, Inc. (ATDS): Entry into a Material Definitive Agreement

Data443 Risk Mitigation, Inc. (ATDS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001068689 0001068689 2026-07-16 2026-07-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Original reporting
Published Jul 20, 2026, 10:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 20, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$ATDS
Neutral
medium confidence
Mentioned
$ATDS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ATDSNeutralMed
01

Why it matters

ATDS becomes obligated under a $2.0M promissory note payable in two installments after the Date of Deal Close, with 15% simple interest applying only upon late payment. If not repaid within 12 months, XYDD may convert outstanding amounts into PubCo shares at 80% of prior 20-trading-day VWAP, subject to a 50% VWAP floor and a 19.99% ownership cap, creating potential dilution overhang.

02

Market read

Traders can reassess ATDS’s near-term financing and dilution risk based on the note’s payment schedule, default interest terms, and conversion mechanics tied to the Date of Deal Close.

03

What to watch

Conversion is discretionary for XYDD and depends on whether the note is fully repaid within 12 months after the Date of Deal Close; the 19.99% cap and 50% VWAP floor can materially limit worst-case dilution.

Relevance 6/10Novelty 7/10Timing: Filed July 20, 2026, describing obligations created on July 16, 2026 and payment/conversion triggers tied to the Date of Deal Close.

Background

The 8-K reports ATDS’s entry into a Compensation Agreement with XYDD after termination of a previously announced business combination between FORL and XYDD, enabling FORL to pursue a proposed combination with ATDS.

Company-level read

Ticker impact

$ATDSNeutralMedium confidence
Context

ATDS entered a Compensation Agreement tied to a terminated FORL-XYDD deal, issuing a $2.0M promissory note with 15% default interest and potential equity conversion.

Expected impact

Near-term volatility risk for ATDS around deal-close timing and any subsequent default or conversion decision; direction depends on perceived dilution overhang versus cash needs.

Evidence & confidence

The filing discloses principal, payment schedule, default interest, and a conversion mechanism with a 19.99% cap, which can affect valuation and capital structure expectations even without immediate cash outflow.

Market effects

Limited direct sector read-across; this is primarily a capital-structure and deal-termination consequence for a microcap.

None indicated.

None indicated.

Counterpoint

If ATDS expects the installments to be paid on time, the note may be viewed as a short-dated, low-cost obligation (no interest when timely), reducing dilution fears.

Key entities

  • ATDS

    Data443 Risk Mitigation, Inc., the registrant issuing the promissory note obligation.

  • XYDD

    Guangzhou Xiaoyu DiDa Technology Co., Ltd., the recipient of the note and potential converter into PubCo shares.

  • FORL

    Four Leaf Acquisition Corporation, whose prior business combination agreement with XYDD was terminated to pursue a combination with ATDS.

Related articles

$EFCMedAI 8/10

Ellington Financial Announces Sale of MSR Assets

Ellington Financial Inc. (EFC) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Ellington Financial Announces Sale of MSR Assets *Completes Monetization of All Material Arlington Assets* OLD GREENWICH, Conn., November 12, 2026—Ellington Financial Inc. (NYSE: EFC) (together with its subsidiaries, the "Company") today announced that it has complet

$CLVTMedAI 8/10

Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, November 12, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration a

$PRMEMedAI 8/10

Prime Medicine Prices $125 Million Stock Offering at $3.50 Per Share

Prime Medicine (PRME) plans to raise $125 million via a public offering of 35.7 million shares at $3.50 each, with an option for $134.7 million if additional shares are purchased. Proceeds will fund disease programs and R&D. The offering is underwritten by Jefferies, TD Securities, and Goldman Sachs, and is expected to close around Nov 12, 2026, according to the company.